VICR Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment NIPG Q2 2025 Earnings Massive EPS Miss and Steep Stock Decline Raise Red Flags NPK Q3 2023 Earnings Earnings per Share of 099 Highlights Modest Quarter InMed Pharmaceuticals Q3 2025 Earnings Continued Losses as Stock Declines RPAY Q1 2026 Earnings Earnings Per Share Surpasses Expectations PLMR Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Not Disclosed